Member overview

DendroPharm GmbH

Key figures / Profile

  • Develop nano carriers to improve drug penetration into skin, tumors and inflamed tissue
  • established a validated route of nanocarrier synthesis
  • used nanocarriers as excipient for a veterinary dermal formulation
  • ISO 9001 certified since 2015

We offer

  • Drug formulation especially using our proprietary nano-carrier platform technology
  • In-vitro transdermal studies for drug formulation development
  • Toxicology rat dermal absorption and metabolism studies
  • Clinical trial samples production (from 2019 onwards)
  • Regulatory Affairs management, veterinary medicine dossier writing, exchange with authorities, veterinary clinical study planning & management,
  • Nanocarrier and other organic chemistry synthesis and nanomaterial & protein purification using diafiltration


Please contact us for further information: